Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C

Relation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients

Influence of vitamin D receptor gene polymorphisms on treatment of chronic HCV patients with interferon

Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

Vitamin D serum level and CYP27B1-1260 promoter polymorphism in chronic hepatitis C patients treated with interferon

Association of transforming growth factor β1 gene polymorphism with natural clearance of hepatitis C virus

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients